MRGPRX1
MOLECULAR TARGETMAS related GPR family member X1
MRGPRX1 (MAS related GPR family member X1) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MRGPRX1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Calcimycin | 1.39 | 3 |
| 2 | Oxcarbazepine | 1.39 | 3 |
| 3 | Pueraria | 0.69 | 1 |
| 4 | Adenosine | 0.69 | 1 |
| 5 | Alprostadil | 0.69 | 1 |
| 6 | Chlorhexidine | 0.69 | 1 |
| 7 | Deoxyuridine 2'-Deoxyuridine. | 0.69 | 1 |
| 8 | gedunin | 0.69 | 1 |
| 9 | Hexachlorophene | 0.69 | 1 |
| 10 | mg624 | 0.69 | 1 |
| 11 | Nisoldipine | 0.69 | 1 |
| 12 | paxilline | 0.69 | 1 |
| 13 | Silymarin | 0.69 | 1 |
| 14 | Stavudine | 0.69 | 1 |
| 15 | Thiorphan | 0.69 | 1 |
About MRGPRX1 as a Drug Target
MRGPRX1 (MAS related GPR family member X1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented MRGPRX1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MRGPRX1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.